GLP-1 / GIPMost PopularHover to zoomQualified Research Reference
TIRZ
TIRZ is documented for controlled research models and literature-based evaluation only.
- Regular
- $149.99
- Elite Member−10%
- $134.99
TIRZ is a synthetic dual GIP/GLP-1 receptor agonist supplied in lyophilized form. Manufactured to research-grade specification for laboratory use only.
Research applications include incretin receptor signaling, glucose homeostasis, appetite-pathway modeling, and metabolic composition studies.
Research Use Only. This product is intended exclusively for laboratory research and is not approved for human or veterinary use.
TIRZ: investigational profile.
Research Mechanism
Investigates dual GIP and GLP-1 receptor activation to model incretin signaling, glucose regulation, appetite pathways, and body-composition changes in preclinical work. Cagrilintide is a frequent comparator arm in amylin-plus-incretin protocols.
Investigational Profile
Published research has expanded rapidly since the late 2010s, focused on receptor selectivity, energy balance, and lipid handling. It sits at the centre of the current dual-agonist incretin literature.
Research Study Window
Weekly-cadence laboratory arms are typically observed across eight- to sixteen-week windows so sustained receptor engagement and downstream metabolic endpoints have time to stabilise.
Pairs With
Cagrilintide
Ingredients, disclosed.
Every compound and formulation strength documented without proprietary blends.
Composition, documented.
- Molecular Formula
- C225H348N48O68
- Molar Mass
- 4813.5 g/mol
- Amino Acid Sequence
- Y-Aib-EGTFTSDYSI-Aib-LDKIAQKAFVQWLIAGGPSSGAPPPS (K20 conjugated to γGlu-γGlu-C20 diacid)
- Synonyms
- LY3298176, GIP/GLP-1 dual receptor agonist
- Solubility
- Water-soluble
- Organoleptic Profile
- White to off-white powder
- Composition
- Lyophilized powder
